Litcius/Paper detail

ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race

J C Ashton

2025Biochemical Pharmacology7 citationsDOI

Topics & Concepts

Anaplastic lymphoma kinaseTimelineLung cancerDrug discoveryDrug resistanceMedicineAcquired resistanceCancer researchCancerBioinformaticsBiologyOncologyInternal medicineGeneticsMalignant pleural effusionArchaeologyHistoryLung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race | Litcius